BlinkLab Limited (ASX: BB1)
Health Care · Health Care Technology · AU
AU$0.67
-3.60% today · +28.8% 1Y
BlinkLab Limited (ASX: BB1) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $72.79M and employs 34 people.
Over the last twelve months the share price has gained 28.8%, trading between 0.44 and 1.11.
Tweenvest scores BlinkLab Limited across four factors: quality 28/100, value 37/100. Its strongest factor is value.
BB1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $72.79M
- Revenue (TTM)
- $835.39K
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 1.33
- 52-week high
- AU$1.11
- 52-week low
- AU$0.44
- Avg volume (3M)
- —
- Shares outstanding
- 153.26M
- Employees
- 34
- Next earnings
- —
About BlinkLab Limited
BlinkLab Limited, founded by neuroscientists, has developed a smartphone-based diagnostic platform for neurodevelopmental conditions like autism and ADHD. The technology uses AI and machine learning for screening tests in children as young as 18 months, aiming for earlier detection and intervention. The company is pursuing FDA approval to facilitate broader use of its technology.
- Founded
- 2021
- Listed since
- Apr 3, 2024
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.27B | $247.90 | -1.05% |
| Pro Medicus LimitedASX: PME | $14.35B | AU$191.60 | -6.99% |
| M3, Inc.TSE: 2413 | $7.17B | ¥1,708.00 | -2.43% |
| Sectra AB (publ)OM: SECT B | $5.66B | Skr278.00 | -1.35% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.80B | $25.01 | +0.68% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $25.33 | -2.35% |
| HeartFlow, Inc.NasdaqGS: HTFL | $3.66B | $49.66 | +18.01% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.